Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Conference on 3rd Annual Pharmaceutical Product Lifecycle ManagementRecognise the major challenges in the pharmaceutical industry and maximise the value of Product Lifecycle Management To be held at 28th - 30th January 2009, London
By: bharatbook.com Recognise the major challenges in the pharmaceutical industry and maximise the value of Product Lifecycle Management To be held at 28th - 30th January 2009, London The pharmaceutical industry is witnessing phenomenal change in the business and regulatory environment. There has been an increase in the complexity of the pharmaceutical products. The Product Lifecycle Management has evolved as an imperative strategic opportunity for the pharmaceutical companies. PLM plays a significant role right from the development of a drug to its long-term establishment on the market. The pharmaceutical companies are adapting the PLM to improve their product oriented process and overcome the challenges. Our 3rd Annual Pharmaceutical PLM conference will address a range of challenges faced by the pharmaceutical industry and methods to develop profitable PLM strategies. Gain qualitative insight into the product lifecycle management solutions Understand the licensing strategies in the product lifecycle management Discover how to extend the brand value of your drugs in the market Learn how to successfully manage regulatory compliance Recognise the challenges in the current pharmaceutical business model Implement and govern a PLM strategy Hear the views regarding favoured PLM strategies from case studies Obtain knowledge on how to streamline the clinical trial supply management process Gain insight into the global drug delivery Industry Who will be there? VPs, Directors, Heads and Managers of: Lifecycle management Marketing and Sales Portfolio Business Development Product and Brand Management Patent Counsel Strategic Planning Strategic Alliances Product and Market Development Patents Sales New product Development Advertising and PR Partners, Counsels, Lawyers, Analysts, Consultants of: Pharmaceuticals Life Sciences Healthcare Key Speakers :- Dr. Jeremy Everett, Global R&D, Pfizer Roger Holdsworth, Associate Director Portfolio Analysis, UCB Group Giovanni Girgenti, Product Manager, Abbott Mike Rea, Chief Executive Offi cer, IdeaPharma Sarah Turner, Of Counsel, Lovells Dr. Charles Harding, Partner, D Young & Co Garreth Duncan, Patent Attorney, D Young & Co Petra Heyen, Vice President Regulatory Affairs and PharmacoVigilance, Therabel Pharma Jo Pisani, Partner –Pharmaceuticals, Price Waterhouse Coopers Markella Kordoyanni, Consultant, Healthcare, Datamonitor Dr. Will Maier, Director, MAPI-EPI Ashish Menocha, Regional Vice President, Aurbindo Pharmaceuticals Sheetal Ranganathan, Assistant Vice President, Evalueserve Workshop Pre-Conference Interactive Workshop Maximising brand assets by excellent Lifecycle Management planning and execution Wednesday 28th January 2009 Led by: Dr Tony Ellery, ellery pharma consulting Former Global Head of Lifecycle Management in Portfolion Management, Novartis 09:30 - 10:00 Coffee & Registration 10:00 - 16:00 Workshop Timing includes refreshment breaks Workshop format The purpose of the workshop is to allow delegates to engage in knowledge sharing with their peers in a smaller, less formal environment than the main conference. As such the audience size will typically be no more than 20 participants in order to enable maximum interaction between the workshop leader and delegates. The format is also more interactive, with less emphasis on ‘lecture-style’ Key topics to be discussed: The changing environment for lifecycle management Structures and processes to optimise lifecycle management Sustainable LCM strategies for the future About your Workshop Leader: Dr Tony Ellery was a practicing veterinarian in the U.K. before moving to the Swiss pharmaceutical industry in Basel in 1974, where he has since occupied positions of increasing seniority in research, development, marketing and sales at different companies, including Roche, Solco, Ciba Vision and Novartis. He led R&D in the Novartis Ophthalmics Business Unit for 8 years, during which time his teams succeeded in gaining 3 NCE approvals each in the US and Europe. For four years, Tony was the Global Head of Development and then Project Management for Novartis’ Mature Products Business Unit, which enjoys sales of over $4 billion per year and is responsible for the seemingly immortal Voltaren (diclofenac) Tony’s last position at Novartis was Global Head of Life Cycle Management (LCM) in Pharma Portfolio Management, advising project and brand teams throughout Novartis on brand strategies and LCM. In 2005 he led a major project on LCM across Novartis Pharma. This led to structural and organizational changes which strengthened the company focus on LCM, also with regard to the interfaces with Novartis’ generics and OTC businesses. Tony has served as a member of the Ciba-Geigy Research Advisory Board and the Novartis Pharma Development Management Board. He has been a member of the faculty of the European Course for Life Science Executives of the University of Basel, lecturing on lifecycle management, and has spoken at many conferences in Europe and the U.S. on lifecycle, project and portfolio management. Tony retired from Novartis in October 2008 to become a consultant to the pharmaceutical industry, especially in the areas of lifecycle and project management. For more information kindly visit: http://www.bharatbook.com/ # # # Bharatbook.com is the leading market research aggregator ever since 1989, providing strategic information tools to business analysts, executives and knowledge managers. Bharat Book provides market research reports, online databases, company profiles, country intelligence, newsletters and customized research services. For more information please visit our website: www.bharatbook.com or call +91 22 2757 8668. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|